Non-melanoma Skin Cancer in Canada Chapter 2: Primary Prevention of Non-melanoma Skin Cancer

被引:9
|
作者
Barber, Kirk [1 ,2 ]
Searles, Gordon E. [3 ]
Vender, Ronald [4 ,5 ]
Teoh, Hwee [6 ]
Ashkenas, John [6 ]
机构
[1] Kirk Barber Res, Calgary, AB, Canada
[2] Univ Calgary, Calgary, AB T2G 1B1, Canada
[3] Searles Dermatol & Aesthet, Edmonton, AB, Canada
[4] Dermat Res, Hamilton, ON, Canada
[5] McMaster Univ, Hamilton, ON, Canada
[6] SCRIPT, Toronto, ON, Canada
关键词
photodamage; photoprotection; sunscreen; artificial tanning; SQUAMOUS-CELL CARCINOMA; SUN PROTECTION FACTOR; RANDOMIZED CONTROLLED-TRIAL; ORGAN TRANSPLANT PATIENTS; CUTANEOUS RISK-FACTORS; REGULAR SUNSCREEN USE; BASAL-CELL; ULTRAVIOLET-RADIATION; P53; MUTATIONS; INDUCED IMMUNOSUPPRESSION;
D O I
10.1177/1203475415576465
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background: Non-melanoma skin cancer (NMSC), including basal and squamous cell carcinoma (BCC and SCC), represents the most common malignancy. Objective: To provide guidance to Canadian health care practitioners regarding primary prevention of NMSC. Methods: Structured literature searches were conducted, using search terms including prevention, sunscreen, and sun prevention factor. All recommendations concern guidance that physicians should regularly discuss with their patients to help establish photoprotection habits. The GRADE system was used to assign strength to each recommendation. Results: Ultraviolet exposure is the major modifiable risk factor for NMSC. Aspects of photoprotection, including effective sunscreen use and avoidance of both the midday sun and artificial tanning, are discussed. Several widespread misunderstandings that undermine responsible public health measures related to sun safety are addressed. Conclusions: Photoprotection represents both an individual priority and a public health imperative. By providing accurate information during routine patient visits, physicians reinforce the need for ongoing skin cancer prevention.
引用
收藏
页码:216 / 226
页数:11
相关论文
共 50 条
  • [41] Non-melanoma skin cancer. Pathogenesis, prevalence and prevention
    Zink, A.
    [J]. HAUTARZT, 2017, 68 (11): : 919 - 928
  • [42] Ultrasound in the management of non-melanoma skin cancer
    Hernandez Ibanez, C.
    Aguilar Bernier, M.
    de Troya Martin, M.
    [J]. ACTAS DERMO-SIFILIOGRAFICAS, 2015, 106 : 21 - 28
  • [43] Current therapy of non-melanoma skin cancer
    Schlaak, M.
    von Bartenwerffer, W.
    Mauch, C.
    [J]. HAUTARZT, 2011, 62 (06): : 430 - 435
  • [44] Epigenomic characterization of non-melanoma skin cancer
    Paredes, M. Rodriguez
    Boldo, L. Sole
    Raddatz, G.
    Gutekunst, J.
    Liberio, M.
    Mallm, J.
    Rippe, K.
    Lonsdorf, A. S.
    Lyko, F.
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2019, 139 (09) : S295 - S295
  • [45] Update of cetuximab for non-melanoma skin cancer
    Wollina, Uwe
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2014, 14 (02) : 271 - 276
  • [46] Photodynamic therapy for non-melanoma skin cancer
    Szeimies, RM
    Morton, CA
    Sidoroff, A
    Braathen, LR
    [J]. ACTA DERMATO-VENEREOLOGICA, 2005, 85 (06) : 483 - 490
  • [47] PHOTOCARCINOGENESIS OF NON-MELANOMA SKIN CANCER: AN UPDATE
    Boeckmann, Lars
    Martens, Marie Christine
    Emmert, Steffen
    [J]. ANTICANCER RESEARCH, 2019, 39 (06) : 3275 - 3276
  • [48] Non-melanoma skin cancer in mouse and man
    Michael Schwarz
    Peter A. Münzel
    Albert Braeuning
    [J]. Archives of Toxicology, 2013, 87 : 783 - 798
  • [49] Non-melanoma skin cancer of the head and neck
    Roland, Nick
    Memon, Aamir
    [J]. BRITISH JOURNAL OF HOSPITAL MEDICINE, 2023, 84 (04)
  • [50] Neoadjuvant Approaches to Non-Melanoma Skin Cancer
    Wilde, David C.
    Glaun, Mica E.
    Wong, Michael K.
    Gross, Neil D.
    [J]. CANCERS, 2023, 15 (23)